Here is what the research shows.

Your immune system already has the cells it needs to fight cancer. Macrophages. NK cells. Dendritic cells. T cells. They are there. But in many cancer patients, these cells are suppressed, exhausted, or simply not activated.

A specific compound, yeast-derived beta glucan, has been studied in clinical trials across multiple cancer types, including pancreatic, breast, colorectal, and lung cancer. All trials used yeast-derived beta glucan specifically. The findings are consistent:

• Safe and well-tolerated across every trial

• Reduces the immune depression caused by chemotherapy and radiation

• Activates innate immune cells through a process called trained immunity, reprogramming them at the epigenetic level

  
  

This is not theory. These are published, peer-reviewed results.

Join us for a live training on Thursday, May 21, 2026 at 7:00 PM ET.

Our presenter is Dr. Michael Karlfeldt, ND, PhD, a board-certified naturopath with over 30 years of integrative oncology experience. He is the founder and director of The Karlfeldt Center in Idaho, where he has treated tens of thousands of patients with non-toxic integrative cancer therapies. He hosts True. Health on Amazon Prime and has been an advocate of yeast-derived beta glucan for his cancer patients for years. He will walk you through the research, the mechanism, and the protocol.

You will learn:

• How beta glucan triggers trained immunity, reprogramming your immune cells at the epigenetic level

• What the clinical trials show across pancreatic, breast, colorectal, lung, and other cancer types

• How this compound reduces the immune depression caused by chemo and radiation

• The gut-to-tumor pathway: how an oral supplement activates immune cells

• Why Dr. Karlfeldt uses this protocol with his own cancer patients

• The specific dosing, timing, and approach Dr. Karlfeldt recommends

  
  

This webinar is for cancer patients, caregivers, and anyone who wants to understand how to support the immune system during and after treatment. The information is grounded in clinical research, and Dr. Karlfeldt will answer your questions live.

Limited registration for this live clinical data presentation.

Practice Integration Call slots are limited by scheduling capacity.